Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-08-27 to 2025-09-18
Current total value of award: $23707.62
Description: 4569270963!XOLAIR 300 MG/2 ML SYRINGE 2ML